Point72 Asia (Singapore) Pte. Ltd. Rapt Therapeutics, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $384 Billion
- Q1 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 7,667 shares of RAPT stock, worth $21,467. This represents 0.02% of its overall portfolio holdings.
Number of Shares
7,667Holding current value
$21,467% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding RAPT
# of Institutions
147Shares Held
29.2MCall Options Held
709KPut Options Held
1.06M-
Column Group LLC San Francisco, CA2.68MShares$7.51 Million15.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.49MShares$6.98 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.47MShares$6.92 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.03MShares$5.68 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.91MShares$5.33 Million0.0% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $83M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...